Article Details

ABVC BioPharma Announces Vitargus® Phase II Study Plan - GlobeNewswire

Retrieved on: 2022-10-05 18:31:19

Tags for this article:

Click the tags to see associated articles and topics

ABVC BioPharma Announces Vitargus® Phase II Study Plan - GlobeNewswire. View article details on hiswai:

Excerpt

FREMONT, CA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up